Healthcare -
Biotechnology - NASDAQ - US
$ 8.67
9.61 %
$ 738 M
Market Cap
-15.76
P/E
AVXL - CHANGE IN WORKING CAPITAL
Change in Working Capital AVXL - Anavex Life Sciences Corp.
2.75 M
LAST VALUE
-28.35%
2 YEAR CAGR
16.15%
5 YEAR CAGR
26.12%
10 YEAR CAGR